Symbiox Investment schedules board meeting for August 26, 2026
- Board meeting scheduled for August 26, 2026, at 2:00 pm in Kolkata
- Agenda includes approval of FY25-26 Director Report and Corporate Governance Report
- Directors to fix dates for 47th AGM and appoint e-voting scrutinizer
- Compliance with SEBI Regulation 29 for listing disclosures

*this image is generated using AI for illustrative purposes only.
Symbiox Investment & Trading Co Ltd has scheduled a meeting of its Board of Directors for August 26, 2026. The session aims to approve the annual report for FY25-26 and finalize logistics for the company’s 47th Annual General Meeting.
The board will convene at 2:00 pm at the company’s registered office in Kolkata. Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the firm notified stock exchanges including BSE, CSE, and MSEI regarding the upcoming proceedings.
Key Agenda Items
The primary focus of the meeting includes administrative and compliance matters related to the conclusion of the fiscal year. The directors will consider and approve the following:
- Director Report and annexures for FY25-26
- Management Discussion and Analysis (MD&A)
- Corporate Governance Report for FY25-26
Additionally, the board will determine the closure dates for the Register of Members and Transfer books. These steps are standard procedural requirements preceding an annual general meeting.
AGM Logistics
The meeting will also address the scheduling and execution details for the 47th Annual General Meeting. Specific actions include:
- Fixing the day, date, time, venue, and calendar of events for the AGM
- Approving the notice for the 47th AGM
- Appointing a scrutinizer to conduct e-voting and poll processes
The board will also take note of the status of statutory registers maintained under the Companies Act, 2013. Any other business may be transacted with the permission of the Chairperson.
Historical Stock Returns for Symbiox Investment & Trading
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| 0.0% | +9.29% | +25.00% | +17.65% | -31.27% | +45.99% |
How might the approved dividend policy for FY25-26, if any, impact Symbiox's stock valuation and investor sentiment post-AGM?
What strategic initiatives or growth plans are likely to be highlighted in the Management Discussion and Analysis (MD&A) for the upcoming fiscal year?
Could the appointment of a specific scrutinizer or changes in e-voting procedures signal any shifts in corporate governance transparency for the company?






























